Singapore markets close in 1 hour 21 minutes
  • Straits Times Index

    -29.33 (-0.94%)
  • Nikkei

    +483.94 (+1.50%)
  • Hang Seng

    -163.50 (-1.00%)
  • FTSE 100

    +40.75 (+0.54%)
  • Bitcoin USD

    -1,671.25 (-3.81%)
  • CMC Crypto 200

    -27.23 (-3.04%)
  • S&P 500

    +18.78 (+0.41%)
  • Dow

    +130.47 (+0.36%)
  • Nasdaq

    +63.97 (+0.45%)
  • Gold

    +1.60 (+0.08%)
  • Crude Oil

    +0.49 (+0.69%)
  • 10-Yr Bond

    0.0000 (0.00%)
  • FTSE Bursa Malaysia

    +1.08 (+0.07%)
  • Jakarta Composite Index

    -62.56 (-0.87%)
  • PSE Index

    -6.48 (-0.10%)

The Zacks Analyst Blog Highlights Novo Nordisk, Suncor Energy, Nasdaq, W.W. Grainger and Textron

For Immediate Release

Chicago, IL – October 3, 2022 – announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Novo Nordisk A/S NVO, Suncor Energy Inc. SU, Nasdaq, Inc. NDAQ, W.W. Grainger, Inc. GWW and Textron Inc. TXT.

Here are highlights from Friday’s Analyst Blog:

Top Analyst Reports for Novo Nordisk, Suncor and Nasdaq

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 12 major stocks, including Novo Nordisk A/S, Suncor Energy Inc. and Nasdaq, Inc. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Novo Nordisk shares have underperformed the Zacks Large Cap Pharmaceuticals industry over the past year (+4.7% vs. +7.1%). The Zacks analyst believes that lower realized prices in the United States, loss of exclusivity for products and stiff competition are affecting the company's sales. Sales are also being negatively impacted by the COVID-19 pandemic. The supply challenges for Wegovy have impacted the stock. The patent expiry on some of the products in Novo Nordisk’s portfolio remains a woe.

However, the promising diabetes drug, Ozempic, is off to a solid start since its launch. The drug remains the growth engine for the company. The launch of Rybelsus also looks impressive. Novo Nordisk has one of the broadest diabetes portfolios in the industry. Drug sales have been gaining and maintaining momentum.

(You can read the full research report on Novo Nordisk here >>>)

Suncor Energy’s shares have advanced +35.1% over the past year against the Zacks Oil and Gas - Integrated - Canadian industry’s gain of +42.8%. The Zacks analyst believes that the company has an impressive supply chain network, owning significant oil sands and conventional production platforms, along with a strong downstream portfolio. Suncor Energy is one of the best positioned companies in the energy space given its access to abundant resources, rich operating experience and technical know-how. Suncor Energy's major projects, including Fort Hills and Syncrude, should support its growth momentum.

The company's strong liquidity and modest near-term debt maturities are other positives. Moreover, Suncor Energy plans to maintain a disciplined capital approach and estimates to repay further debt in 2022, thereby indicating its ability to generate cash flow.

(You can read the full research report on Suncor Energy here >>>)

Nasdaq shares have outperformed the Zacks Securities and Exchanges industry over the past three-month period (+10.1% vs. -4.4%). The Zacks analyst believes that the company has been successful in maximizing opportunities as a technology and analytics provider and growing core marketplace businesses. Focus on growth via acquisitions and organic initiatives, which aided its entry into new markets and helped it gain cross-selling opportunities, bodes well. Intense focus on Market Technology and Information Services businesses also helps the company to explore vast opportunities per its developmental strategies.

Nasdaq remains committed to deploy capital effectively by investing in organic growth initiatives. Its board announced a three-for-one stock split in the form of a stock dividend. However, high expenses weigh on margin expansion. High leverage ratio poses risk.

(You can read the full research report on Nasdaq here >>>)

Other noteworthy reports we are featuring today include W.W. Grainger, Inc. and Textron Inc.

Why Haven’t You Looked at Zacks' Top Stocks?

Our 5 best-performing strategies have blown away the S&P's impressive +28.8% gain in 2021. Amazingly, they soared +40.3%, +48.2%, +67.6%, +94.4%, and +95.3%. Today you can access their live picks without cost or obligation.

See Stocks Free >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit for information about the performance numbers displayed in this press release.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Textron Inc. (TXT) : Free Stock Analysis Report
Nasdaq, Inc. (NDAQ) : Free Stock Analysis Report
Novo Nordisk AS (NVO) : Free Stock Analysis Report
Suncor Energy Inc. (SU) : Free Stock Analysis Report
W.W. Grainger, Inc. (GWW) : Free Stock Analysis Report
To read this article on click here.
Zacks Investment Research